Loading...
| A03785 | Pages: NA | Aug 2021 | 3854 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Global Left Atrial Appendage (laa) Closure Devices Market
Request Now !The left atrial appendage (LAA) is a small ear-shaped sac which is present in the wall of the top left chamber of the heart. This sac controls the electrical impulses during atrial fibrillation. The LAA closure devices are the interventional devices that is used to prevent stroke and emboli caused due to atrial fibrillation.
Factors such as increase in number of product approvals of atrial intervention, rise in incidences of atrial fibrillation and heart stroke cases, rise in aging population, disorders due to hypertension, and disturbed lifestyle habits such as smoking drive the market growth. However, stringent regulations by government and high acceptance of alternatives drugs such as warfarin and dabigatran restrain the market growth. Moreover, increase in awareness programs in untapped market provide numerous opportunities for the market growth in the forecast period.
The left atrial appendage closure devices market is segmented on the basis of product, end user, and geography. On the basis of product, it is bifurcated into epicardial LAA closure devices and endocardial LAA closure devices. On the basis of end user, it is divided into heart clinics, hospitals, and ambulatory service centers. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players operating in the market include AtriCure, Inc., Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Inc., Avantis Medical Systems, United-Guardian, Inc., and Carestream Health.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EPICARDIAL LAA CLOSURE DEVICES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. ENDOCARDIAL LAA CLOSURE DEVICES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HERAT CLINICS
5.2.1. Market size and forecast
5.3. HOSPITALS
5.3.1. Market size and forecast
5.4. AMBULATORY SERVICE CENTERS
5.4.1. Market size and forecast
CHAPTER 6 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.2.5. North America Left Atrial Appendage (LAA) Closure Devices Market, by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.3.5. Europe Left Atrial Appendage (LAA) Closure Devices Market, by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.4.5. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast
6.5.4. LAMEA Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.5.5. LAMEA Left Atrial Appendage (LAA) Closure Devices Market, by End User
CHAPTER 7 COMPANY PROFILES
7.1. ATRICURE, INC.
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. BOSTON SCIENTIFIC CORPORATION
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. COHEREX MEDICAL
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. ST. JUDE MEDICAL
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. OCCLUTECH
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. LIFETECH SCIENTIFIC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. SENTREHEART, INC.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. AVANTIS MEDICAL SYSTEMS
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. UNITED-GUARDIAN, INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. CARESTREAM HEALTH
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
